A20 regulates canonical wnt-signaling through an interaction with RIPK4. Read more about A20 regulates canonical wnt-signaling through an interaction with RIPK4.
Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis. Read more about Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.
Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination. Read more about Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.
TGF-β1/CD105 signaling controls vascular network formation within growth factor sequestering hyaluronic acid hydrogels. Read more about TGF-β1/CD105 signaling controls vascular network formation within growth factor sequestering hyaluronic acid hydrogels.
Determining gestational age and preterm birth in rural Guatemala: A comparison of methods. Read more about Determining gestational age and preterm birth in rural Guatemala: A comparison of methods.
Quantifying population-level health benefits and harms of e-cigarette use in the United States. Read more about Quantifying population-level health benefits and harms of e-cigarette use in the United States.
Methylglyoxal-bis-guanylhydrazone inhibits osteopontin expression and differentiation in cultured human monocytes. Read more about Methylglyoxal-bis-guanylhydrazone inhibits osteopontin expression and differentiation in cultured human monocytes.
Short term dynamics of the sputum microbiome among COPD patients. Read more about Short term dynamics of the sputum microbiome among COPD patients.
Adherence to antiretroviral therapy in a clinical cohort of HIV-infected children in East Africa. Read more about Adherence to antiretroviral therapy in a clinical cohort of HIV-infected children in East Africa.
Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes. Read more about Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes.
